Breathing easier.

Position:NO COMMENT - Mylan Inc. chief Heather Bresch - Brief article
 
FREE EXCERPT

Heather Bresch, the CEO of the pharmaceutical company Mylan, told CNBC, "No ones more frustrated than me" that the price of her company's potentially life-saving EpiPen injectors rose by about 400 percent between 2007 and 2015. Bresch's hurt maybe somewhat assuaged by the fact that...

To continue reading

FREE SIGN UP